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Abstract
NrCAM (Neuron-glial related cell adhesion molecule), a member of the L1 family of cell adhesion molecules, reversibly binds
ankyrin and regulates axon growth, but it has not been studied for a role in retinotopic mapping. During development of
retino-collicular topography, NrCAM was expressed uniformly in retinal ganglion cells (RGCs) along both mediolateral and
anteroposterior retinal axes, and was localized on RGC axons within the optic tract and superior colliculus (SC). Anterograde
tracing of RGC axons in NrCAM null mutant mice at P10, when the map resembles its mature form, revealed laterally
displaced ectopic termination zones (eTZs) of axons from the temporal retina, indicating defective mediolateral topography,
which is governed by ephrinB/EphBs. Axon tracing at P2 revealed that interstitial branch orientation of ventral-temporal
RGC axons in NrCAM null mice was compromised in the medial direction, likely accounting for displacement of eTZs. A
similar retinocollicular targeting defect in EphB mutant mice suggested that NrCAM and EphB interact to regulate
mediolateral retino-collicular targeting. We found that EphB2 tyrosine kinase but not an EphB2 kinase dead mutant,
phosphorylated NrCAM at a conserved tyrosine residue in the FIGQY ankyrin binding motif, perturbing ankyrin recruitment
in NrCAM transfected HEK293 cells. Furthermore, the phosphorylation of NrCAM at FIGQY in SC was decreased in EphB1/3
and EphB1/2/3 null mice compared to WT, while phospho-FIGQY of NrCAM in SC was increased in EphB2 constitutively
active (F620D/F620D) mice. These results demonstrate that NrCAM contributes to mediolateral retinocollicular axon
targeting by regulating RGC branch orientation through a likely mechanism in which ephrinB/EphB phosphorylates NrCAM
to modulate linkage to the actin cytoskeleton.
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Introduction
Topographic targeting of retinal ganglion cells (RGCs) to the
superior colliculus (SC) of the midbrain is a developmental process
in which precise spatial ordering of RGC axon terminations is
established along orthogonal axes. RGC axons from temporal-
nasal axis of the retina target along the anterior-posterior SC axis,
while dorsal-ventral RGC axons target along lateral-medial SC
axis. Studies on the mechanism by which this highly ordered
mapping is achieved have indicated a vital function of ephrin/Eph
signaling in axon guidance. Complementary gradients of ephrinA
ligands in the SC and EphA receptors in the retina control the
mapping of temporal-nasal RGC axons along anterior-posterior
axis of the SC, while counter gradients of ephrinBs in the SC and
EphBs in the retina play a major role in dorsal-ventral mapping of
RGC axons along the mediolateral axis of the SC [1–3]. Repulsive
Wnt/Ryk signaling contributes to mediolateral mapping by
counterbalancing ephrinB/EphB-mediated medial attraction [4].
However, these molecular determinants do not fully account for
retinotopic mapping.
NrCAM is a member of the L1 family of immunoglobulin-class
cell adhesion molecules (L1, NrCAM, CHL1, Neurofascin), and
has important functions in axon guidance and myelination during
brain development [5]. NrCAM is implicated in neuropsychiatric
disorders including autism [6–10] and schizophrenia [11,12], as
well as addiction-related behaviors [13,14]. NrCAM mediates
topographic targeting of thalamocortical axons [15], and ipsilat-
eral guidance of RGC axons at the optic chiasm [16] but a role in
retino-collicular mapping has not been examined. The closely
related molecule L1 is required for topographic targeting of RGC
axons along both mediolateral and anteroposterior axes of the SC
[17,18]. NrCAM and L1 associate with ALCAM, an immuno-
globulin-class adhesion molecule that is expressed as a substrate-
bound ligand in the SC and functions in mediolateral retinocolli-
cular mapping [19]. The intracellular region of NrCAM harbors a
motif (FIGQY) that is highly conserved among L1 family
members, and reversibly engages the actin adaptor ankyrin [20].
L1 mutant mice with a pathogenic substitution of tyrosine1229 for
histidine in the FIGQY1229 motif exhibit mediolateral retinocolli-
cular mapping defects due to loss of ankyrin binding [18]. Similar
mediolateral targeting defects of retinocollicular axons in EphB
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receptor mutant mice [21,22] suggest a possible combinatorial
interaction among L1 family members and ephrinB/EphBs in
development of retinotopy.
To determine if NrCAM contributes to retino-collicular
topography, we analyzed NrCAM null mutant mice [23] by axon
tracing during the postnatal development of the retinotopic map.
We found that loss of NrCAM resulted in mistargeting of temporal
RGC axons along the mediolateral SC axis, and compromised the
ability of RGC axons to medially orient their interstitial branches.
Moreover, EphB receptors were found to induce phosphorylation
of NrCAM on the tyrosine residue within the FIGQY ankyrin
binding motif, inhibiting ankyrin recruitment. Furthermore,
NrCAM phospho-FIGQY levels in the SC were decreased in
EphB1/3 and EphB1/2/3 null mice and increased in mutant
mice overexpressing constitutively active EphB2 kinase. These
results are consistent with the interpretation that ephrinB/EphB
signaling regulates NrCAM-ankyrin binding to modulate intersti-
tial branch attraction within the SC necessary for proper mapping
of RGC axon subpopulations along the mediolateral SC axis.
Materials and Methods
Ethics Statement
Mice were maintained and handled ethically according to all of
the Institutional Animal Care and Use Committee policies of the
University of North Carolina at Chapel Hill (PHS Animal Welfare
Assurance number, A3410-01). The UNC IACUC specifically
approved this study (protocol no.10.030).
Mice
NrCAM null mutant (knockout) mice were originally generated
in the W4 ES cell line 129S6/EvSvTaconic by homologous
recombination, and maintained on a hybrid background of
129S6/EvSvTaconic and Swiss Webster (CFW), as reported
previously [23]. NrCAM null (KO) and wild-type (WT) littermates
were generated by intercrossing NrCAM heterozygotes and
genotyping offspring by PCR.
Axon Tracing and Analysis
Anterograde tracing of retinocollicular axon was performed as
described [17–19,21]. Briefly, NrCAM null mutants and WT
littermates at P2 or P8 were focally injected with a DiI tracer (10%
in dimethylformamide) into the peripheral retina by a picospritzer.
After 24 hour (labeled at P2) or 48 hour (labeled at P8), mice were
anesthetized and perfused transcardially with 4% paraformalde-
hyde (PFA) in 0.1 M phosphate-buffered saline (PBS). The
injection site was identified according to the insertion of the
extraocular muscles (lateral and inferior recti). Afterwards, the
retina was dissected out and demarcated the quadrants. To verify
the injection sites and analyze the termination zones (TZs), the
injected retina, superior and inferior colliculi were whole mounted
onto slides and observed by epifluorescence and confocal
microscopy. Those with injection sites covering about 3–5% of
the retina were analyzed. Termination zones of labeled RGC
axons in the SC were identified by their densely branched
appearance.
To quantitatively analyze branch orientation of VT RGC axons
at P3, the SC was divided into three bins: lateral to TZ, within TZ
and medial to TZ as described previously [17–19,21]. Only
mutants with one normally positioned TZ were analyzed. The
total number of labeled axons and branches were counted in
confocal microscopy, and medial or lateral branch orientation for
each bin was recorded. For each bin, the number of medially
oriented branches minus that of laterally oriented branches was
divided by the total number of branches to reach the final
directional coefficient (DC). The DC for each bin was compared
between WT and NrCAM null mice by single-factor ANOVA
with significance at p,0.05.
To analyze the entrance location of VT RGC axons in SC, the
SC of WT and NrCAM null mice was divided into ten bins: four
bins medial to the TZ and six bins lateral to the TZ as described
previously [17–19,21]. For each bin, the percent of axons entering
the SC was scored for each mouse and averaged over groups. The
entrance location of RGC axons was compared between WT and
NrCAM null mice by single-factor ANOVA (p,0.05).
Cell Culture, Immunoprecipitation and Immunoblotting
HEK293T cells were cultured in DMEM with 10% bovine fetal
serum (FBS). Plasmids encoding mouse NrCAM, chicken EphB2
and EphB2 kinase dead mutant (EphB2K662R; EphB2 KD) [24],
mouse EphB1with a hemagglutinin epitope (HA) tag, mouse
EphB2, and mouse EphB3 with HA tag were transfected into
HEK293T cells using Lipofectamine 2000 (Invitrogen). After 48
hours, cells were washed with Hank’s Balanced Salt Solution and
lysed in RIPA buffer containing protease inhibitors and phospha-
tase inhibitors (1% NP-40, 1% sodium deoxcholate, 0.1% sodium
dodecyl sulfate, 0.15 M NaCl, 5 mM Na-EDTA, 1 mM Na-
EGTA in 20 mM Tris-HCl, pH 7.0, 10 mg/mL leupeptin,
0.11 TIU/mL aprotinin, 0.2 mM sodium orthovanadate, and
10 mM sodium fluoride). The SC (P2-P3) was dissected from WT,
EphB1/3 double null mice, EphB1/2/3 triple null mice [25,26],
and from homozygous mutant mice expressing a constitutively
overactive EphB2 kinase (F620D) that harbors a point mutation
(F620D) conferring forward signaling independent of ligand
binding [27,28]. SC preparations were homogenized in RIPA
buffer containing protease and phosphatase inhibitors.
Lysates (500 ug) were immunoprecipitated with rabbit anti-
NrCAM antibody (5 ug; Abcam, ab24344) or normal rabbit IgG
for 2 hour at 4uC, then incubated with protein A/G-Sepharose
beads (Pierce Biotechnology, Rockford, IL) for 1 hour. Beads were
washed with RIPA buffer, and proteins were eluted by boiling in
SDS-PAGE sample buffer. The immunoprecipitates were resolved
on 7.5% SDS-PAGE gels and transferred to nitrocellulose
membranes. After blocking in 5% non-fat dry milk, the
membranes were immunoblotted with rabbit anti-p-FIGQY
antibody (1:500), and reprobed with rabbit anti-NrCAM
(0.4 ug/ml; Abcam, ab24344), mouse anti-EphB2 (1:250; Invitro-
gen, 37–1700) or mouse anti-HA (1:1000; BaBco, HA-11)
antibodies. Bands were developed on X-ray film by enhanced
chemiluminescence (Perkin-Elmer, Waltham, MA).
Immunohistochemistry
Postnatal WT mice at day 0 (P0) and day 6 (P6) were
anesthetized by hypothermia and perfused transcardially with 4%
PFA/PBS. The brains or entire heads were post-fixed in 4% PFA
in PBS overnight at 4uC and sectioned in a cryostat after
cryoprotection with 30% sucrose in PBS. After blocking in 2%
BSA/10% normal donkey serum/0.2% Triton x-100 in PBS at
room temperature for 2 hours, sections were incubated with rabbit
anti-NrCAM polyclonal antibody (1:200; Abcam, AB24344), rat
anti-L1 monoclonal antibody (1:200; Millipore, MAB5272), or
mouse anti-neurofilament 165 antibodies (1:500; Developmental
Studies Hybridoma Bank, 2H3), or a combination of rat anti-L1
and mouse anti-neurofilament 165 at room temperature for 2
hours. Signals were developed by incubating sections with FITC-
conjugated donkey anti-rat or anti-rabbit IgG (1:200; Jackson
Immunoresearch) with Cy3-conjugated donkey anti-rabbit or anti-
mouse IgG (1:200; Jackson Immunoresearch) for 1 hour at room
NrCAM Promotes Retinocollicular Mapping
PLOS ONE | www.plosone.org 2 September 2013 | Volume 8 | Issue 9 | e73000
Figure 1. Early Postnatal Expression of NrCAM in the Retina and Superior Colliculus. A. Immunofluorescence staining for NrCAM (red) in
mouse retina at P0 and P6 demonstrated NrCAM localization in fibers of the retinal NFL, ON, IPL, and lens, as shown in confocal images. Double
staining for L1 (green) showed partial co-localization with L1. GCL, ganglion cell layer; NFL, nerve fiber layer; IPL, inner plexiform layer; ON, optic nerve
head; OPL, outer plexiform layer; L, lens; D, dorsal; V, ventral. B. In situ hybridization with antisense probes in the mouse retina (P0) showed NrCAM
transcripts in cell bodies in the GCL. L1 transcripts were present in the GCL and inner nuclear layer (INL). Background labeling of retina is shown by
hybridization with the NrCAM sense probe. C. Immunofluorescence staining for NrCAM in sagittal sections of SC at P0 showed partial co-localization
with the axonal marker NF165 in a portion of RGC axons in the SGS and SO, as well as some additional labeling within the SC. SGS, stratum griseum
superficiale; SO, stratum opticum. D. In situ hybridization with antisense probe showed NrCAM transcripts in cell bodies located within the SC (P0,
sagittal sections). Background is indicated by hybridization with the NrCAM sense probe.
doi:10.1371/journal.pone.0073000.g001
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temperature. Images were obtained by Zeiss 710 confocal
microscopy after DAPI counterstaining.
NrCAM-ankyrin Recruitment Assay
Ankyrin recruitment to NrCAM in the plasma membrane was
performed as described previously for L1-ankyrin recruitment
[29,30]. HEK293T cells were cultured on poly-D-lysine coated
Mat-Tek dishes in DMEM-10% FBS and transfected with plasmid
pEGFP-N1 expressing ankyrinG-EGFP fusion protein [31],
pcDNA3 plasmid expressing rat NrCAM, and/or pcDNA3
plasmid expressing chicken EphB2 or the EphB2 kinase dead
mutant [24] using lipofectamine 2000 (Invitrogen). Expression of
EphB receptors in HEK293T cells results in autoactivation, typical
for receptor tyrosine kinases, such that treatment with ephrinB1
ligands does not further increase phospho-FIGQY levels [32].
After 18 hours, cells were fixed in 4% PFA/PBS and blocked in
10% normal donkey serum+2%BSA+0.05% Triton X-100 in
PBS. Cells were subjected to immunofluorescence staining with
antibodies against the extracellular region of NrCAM (Abcam,
ab24344; 1:400) or EphB2 (Invitrogen, 36–6100; 1:200) using Cy3
donkey anti-rabbit secondary antibody. Confocal images were
captured using the 488 nm and 543 nm excitation lines of the
lasers for ankyrin-EGFP and Cy3, respectively. Cells were scored
in 3 replicate cultures for the percent of cells that display ankyrin-
EGFP recruited to the cell surface using criteria described in [29].
Means 6 S.E.M. were compared for statistically significant
differences using one-way ANOVA and Tukey’s post-hoc com-
parisons (p,0.001).
Results
NrCAM is Expressed in Retinal Axon Subpopulations
during Retinocollicular Mapping
Retinocollicular mapping in the mouse begins around embry-
onic day 14 (E14), when RGC axons first reach the anterior SC.
Axons subsequently grow into the stratum griseum superficiale
(SGS) and stratum opticum (SO) layers of the SC by postnatal day
0 (P0), overshooting their final termination zones (TZs) [33,34].
RGC axons remodel postnatally from P0 to P10 by a combination
of interstitial branching and axon retraction to form correctly
targeted final TZs in the SC. To determine if NrCAM might play
a role in RGC axon mapping, NrCAM expression was analyzed
during early postnatal stages of retinocollicular map refinement. At
P0 NrCAM immunostaining was most prominent in the nerve
fiber layer (NFL), containing processes of RGC axons, and could
also be seen in the developing inner plexiform layer (IPL) (Fig. 1A).
Smaller amounts of radially oriented NrCAM staining were
evident spanning the retina and ganglion cell layer (GCL)
suggested of Mller glia labeling. Double immunostaining for L1
showed that NrCAM colocalized in part with L1 in the NFL, and
to a lesser extent in the IPL (Fig. 1A). NrCAM was present in the
optic nerve head (ON) at lower levels than L1. NrCAM was also
localized on fibers of the lens (Fig. 1A), as previously reported [35],
and partly colocalized with L1. NrCAM expression in the NFL
persisted at P6 but less strongly than L1, but increased in the IPL
(Fig. 1A). In situ hybridization using anti-sense probes specific for
NrCAM and L1 demonstrated the presence of NrCAM and L1
transcripts in cell bodies in the GCL at P0, although it was difficult
to assess co-expression even at higher magnification (Fig. 1B). No
positive signal was observed in retina with the control sense probe
for NrCAM (Fig. 1B). Gradient expression of NrCAM or L1 in the
dorsal-ventral retinal axis was not prominent by immunostaining
or in situ hybridization, though there may be a slight enrichment
dorsally (Fig. 1 A,B). Graded expression was not observed in the
nasal-temporal axis of the retina (not shown).
In the early postnatal SC (P0), immunostaining for NrCAM and
the pan-axonal marker neurofilament NF165 showed NrCAM
localized on NF165-positive subpopulations of fibers in the SGS
and SO, where RGC axons enter the SC (Fig. 1C). Some NrCAM
staining did not colocalize with fibers in the SC. In situ
hybridization at P0 confirmed that NrCAM was also expressed
in cell bodies located in the SC at P0 (Fig. 1D). The expression of
NrCAM in early postnatal retina is in accord with its expression in
RGCs at embryonic stages [16]. The pattern of expression of
NrCAM in the retina and SC during postnatal stages of RGC
axon pathfinding in the SC suggested that it may be involved in
retinocollicular targeting in a subpopulation of RGC axons.
NrCAM Null Mutant Mice Display Mediolateral
Retinocollicular Mapping Errors
To investigate whether NrCAM has a functional role in
development of retinocollicular topography, we mapped the
projections of RGC axons to the SC in wild type (WT) and
NrCAM null mutant mice by anterograde axon tracing with the
lipophilic dye, DiI, when the map resembles its mature form (P8–
Figure 2. Medial-lateral Targeting Defects of RGC Axons in the Superior Colliculus of NrCAM Null Mice. A. In WT mice, DiI injection into
the temporal retina at P8 labeled a single dense termination zone (TZ) in the anterior SC at P10. B–D. In NrCAM null (KO) mice, DiI injection into the
temporal retina labeled multiple laterally displaced ectopic TZs (eTZs) in the SC at P10. E–F. DiI injections into the nasal retina labeled a single TZ in
the posterior SC that was normally positioned in WT and NrCAM KO mice at P10. G–H. DiI injections into the dorsal (G) and ventral (H) retina of
NrCAM KO mice resulted in normally positioned single TZs in the lateral (G) and medial (H) SC, respectively. The location of DiI injections were shown
in retinal flat mounts in the lower left of each image. L, lateral; M, medial; A, anterior; P, posterior; D, dorsal; V, ventral; T, temporal; N, nasal.
doi:10.1371/journal.pone.0073000.g002
Figure 3. Distribution and Percentage of Termination Zones of
Temporal RGC axons in the NrCAM Null Superior Colliculus.
Left panel: The schematic diagram illustrates the location of TZs of
temporal RGC axons in the NrCAM null mutant (KO) SC (P10). The
centers of TZs and eTZs from NrCAM KO mice (n = 14) are marked and
connected. The distribution of normal TZs of temporal RGC axons in WT
mice are all found within the anterior region of the SC depicted by the
oval. L, lateral; M, medial; A, anterior; P, posterior. Right panel:
Percentage of abnormally distributed single and multiple eTZs of
temporal RGC axons in the SC of NrCAM null mice (P10). In NrCAM KO
mice 85% of mice showed abnormally located eTZs. A single laterally
displaced eTZ is found in 14% of mutants, and multiple eTZs were
found in 71% of the mutants.
doi:10.1371/journal.pone.0073000.g003
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10). DiI was focally injected into the midpoint of temporal, nasal,
dorsal or ventral quadrants of the peripheral retina in live mice at
P8, and labeled RGC projections were analyzed 2 days later in the
SC. During retinocollicular map formation, RGC axons along the
temporal-nasal axis of the retina project to the anterior-posterior
axis of the contralateral SC. Temporal retinal injections label
RGC terminals in the anterior SC; nasal injections label terminals
in the posterior SC [1,36–39]. Conversely, projections of RGC
axons along the D-V retinal axis project to the lateral-medial axis
of the SC, such that ventral injections label terminals in the medial
SC and dorsal injections label terminals in the lateral SC
[4,21,22,40].
DiI injections into the mid-temporal (T) retina of WT mice
labeled a single dense termination zone (TZ) in the mid-anterior
region of the contralateral SC (Fig. 2A). In contrast, temporal
injections into the retina of NrCAM null mutant mice resulted in
aberrant labeling of RGC axons displaced along the mediolateral
axis of the contralateral SC. The location and size of DiI injections
are shown in retinal flat mounts. A large majority (12/14) of
NrCAM mutants (,85%) showed lateral mistargeting of temporal
RGC axons in the SC, resulting in eTZs (Fig. 2B–D). Most of
these (10/14) displayed multiple laterally displaced eTZs in
addition to one correctly positioned TZ in the mid-anterior SC
(Fig. 2C,D), similar to EphB2/B3 double mutants [21] and L1
mutant mice [17,18]. A minority of NrCAM mutants (,14%; 2/
14) exhibited a single laterally displaced eTZ without a normally
positioned TZ (Fig. 2B), which may result from greater malpo-
sitioning of axons to form eTZs or to individual variation in
NrCAM mutant mice. In addition, the more laterally eTZs were
displaced in the SC of NrCAM null mice, the more likely they
were to be slightly shifted posteriorly (Fig. 2B–D). A schematic
representation of TZs of temporal RGC axons from NrCAM null
mutants depicts their relative positions in the SC, compared to the
normal distribution of WT TZs (circled area in mid-anterior SC)
(Fig. 3).
We also examined retino-collicular targeting of RGC axons
from other quadrants of the retina. The targeting of nasal RGC
axons to the SC was not perturbed in NrCAM null mice. Nasal
injections into the NrCAM mutant retina (7/7) labeled a normally
positioned single TZ in the posterior region of the contralateral SC
at the same location as in WT mice (Fig. 2E,F). Ventral or dorsal
RGC axons of NrCAM mutant mice also terminated at
appropriate locations in the SC. Dorsal injections of NrCAM
mutant retinas (6/6) resulted in labeling of a single TZ in the
lateral SC (Fig. 2G). Similarly, projections from ventral retina of
Figure 4. Interstitial Branching of Ventrotemporal RGC axons in WT and NrCAM null SC at P3. A–C. DiI labeling of VT RGC axons in WT
mice showed that most branches from VT axons in the lateral zone of the SC oriented medially to the future SC, as seen in a higher magnification of
the boxed area in B (arrows). D–F. DiI labeling of VT axons in NrCAM null mutants (KO) revealed more laterally oriented branches in axons within the
lateral zone of the SC, as seen in a higher magnification of the boxed area in E (arrows). M, medial; L, lateral; P, posterior. Scale bar: 200 mm in A,D;
100 mm in B,E; 50 mm in C,F.
doi:10.1371/journal.pone.0073000.g004
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NrCAM null mice (7/7) terminated as a single TZ in the medial
SC (Fig. 2H).
Thus, topographic targeting of RGC axons from the temporal
retinal quadrant, but not from nasal, dorsal or ventral retina, was
sensitive to loss of NrCAM and resulted in single or multiple eTZs
that were laterally displaced along the mediolateral axis of the SC.
Interstitial Branches of Remodeling RGC Axons are
Misoriented in the NrCAM Null Superior Colliculus
During remodeling of overshooting RGC axons in the SC,
interstitial branches form along the axon shaft (,P2) with a
mediolateral bias for the topographically correct site of their future
TZ by a balancing mechanism between attractant and repellent
forces including ephrinB/EphB and Wnt3/Ryk signaling
[4,21,40]. Because RGC axons from the ventrotemporal (VT)
retina form TZs more medially within the anterior SC than mid-
temporal axons, any bias for misoriented branches in mutants
would be more evident in this subpopulation. To investigate the
mechanism for incorrect TZ positioning of RGC axons in
NrCAM null mutants, we labeled VT axons of WT and NrCAM
null mice with DiI at P2 and quantitatively analyzed interstitial
branches in the SC at P3. In WT mice DiI-labeled VT axons were
diffusely spread along the mediolateral axis of the SC and
extended into the posterior SC (Fig. 4A–C). Interstitial branches
from WT axons preferentially oriented toward the correct
terminal location in the anteromedial SC, as shown by medially
directed branches of axons in the lateral SC (Fig. 4C, arrows). In
contrast, interstitial branches from NrCAM null mutant axons
tended not to be correctly oriented (Fig. 4D–F), as shown by many
laterally oriented branches in the lateral SC (Fig. 4F, arrows).
For quantification of branch orientation (Fig. 5A), the SC was
divided into three bins along the medial-lateral axis relative to the
location of the emerging TZ as follows: lateral to TZ (L), within
Figure 5. Branching and Entry Position of RGC Axons in the Superior Colliculus of WT and NrCAMNull Mice. A. Diagram of the location
and branch orientation of DiI-labeled axons from the VT retina within the SC of WT mice at P3. The SC was divided into 3 bins along the medial-lateral
axis as shown by the dashed lines: lateral to TZ (L), within TZ (TZ), and medial to TZ (M). The shaded circle represents the site of the forming TZ.
Branches were scored and their orientations were analyzed within each bin. The arrows represent the preferred orientation of WT branches. B. Branch
distribution of VT RGC axons in WT and NrCAM null mutant (KO) mice. The distribution of branches was expressed as a branch directional coefficient
for each bin by subtracting the number of laterally oriented branches from medially oriented branches, then dividing by the total number of
branches. In WT (n = 4) and NrCAM null (n = 4) mice, 184 and 205 branches were analyzed, respectively. Brackets indicate S.E.M., and asterisks show
significant differences (ANOVA, p,0.05). C. Diagram of entry position of VT RGC axons in the SC of WT mice at P3. The SC was divided into 10 equal
segments along the medial-lateral axis at its anterior border relative to the position of the forming TZ: lateral to TZ (L), within TZ (TZ), and medial to
TZ (M). The position of labeled RGC axons in each segment was scored and expressed as the percent of total axons. D. Distribution of DiI-labeled VT
RGC axons of WT and NrCAM null mutant (KO) mice entering the anterior SC (expressed as the percent of total axons) in bins along the mediolateral
axis, as described in C. Shaded circle indicates region near the location of normal TZ. In WT (n = 4) and NrCAM null (n = 4) mice, 146 and 167 axons
were analyzed, respectively. Error bars represent SEM. There were no significant differences between WT and mutant at any location (ANOVA,
p,0.05).
doi:10.1371/journal.pone.0073000.g005
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Figure 6. EphB receptors Induce Tyrosine Phosphorylation of NrCAM at the FIGQY Motif, and Inhibit Ankyrin Recruitment in
HEK293 cells. A. NrCAM was expressed with or without EphB2 or EphB2 kinase dead mutant (EphB2 KD) in transfected HEK293 cells, followed by
immunoprecipitation with NrCAM antibodies and immunoblotting with phospho-FIGQY antibodies. EphB2 induced phosphorylation of NrCAM
(200 kD) at FIGQY (p-FIGQY) compared to NrCAM alone or to co-expression of the EphB2 kinase dead mutant. Blots were stripped and reprobed with
antibodies to NrCAM to indicate relative levels of NrCAM in the immunoprecipitates. B. NrCAM was expressed with or without EphB1, EphB2, or
EphB3 in transfected HEK293 cells, followed by immunoprecipitation with NrCAM antibodies and immunoblotting with phospho-FIGQY antibodies.
EphB1 (HA-tagged) or EphB2 (not HA-tagged) induced effective phosphorylation of NrCAM at FIGQY, whereas EphB3 (HA-tagged) had a weak effect.
Blots were stripped and reprobed with antibodies to EphB2 or to the HA-epitope on EphB1 and EphB3. Each EphB receptor was co-
immunoprecipitated efficiently with NrCAM. C. Lysates of the superior colliculus from WT, EphB1/3 double null, EphB1/2/3 triple null and
constitutively active EphB2 (F620D) homozygous mice (P2-P3) were immunoprecipitated with antibodies to NrCAM, and immunoblotted with
phospho-FIGQY or NrCAM antibodies. Bands were quantified using the threshold function of ImageJ. The numbers under the blots represent the
normalized average phospho-FIGQY/NrCAM band intensity from individual mice. Phosphorylation of NrCAM at FIGQY was reduced in the SC of
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TZ (TZ), and medial to TZ (M). In each bin, the total number of
labeled RGC axons and branches was measured, and medial or
lateral branch orientation of each branch was scored (Fig. 5A–B).
A directional coefficient (DC) was calculated by subtracting the
number of laterally oriented branches from medially oriented
branches, and dividing the result by the total number of branches,
as previously described [18,19,21]. A positive DC indicated that
there were more medial than lateral branches; a negative DC
indicated more lateral than medial branches. This analysis
revealed that interstitial branches of VT axons in WT mice
(n = 4) preferentially oriented along the mediolateral axis toward
the position of the future TZ (Fig. 5A,B), confirming previous
studies [18,19,21]. Most branches in the lateral bin were oriented
medially with respect to the TZ, as indicated by a positive DC;
branches within the TZ were largely unbiased; and most branches
in the medial bin were laterally oriented to the TZ, as indicated by
a negative DC (Fig. 5B). In contrast, many more interstitial
branches of VT axons in the lateral bin of NrCAM null mice
(n = 5) were oriented laterally, as indicated by a decreased DC
compared to WT. (Fig. 5A,B). Branch orientation was significantly
different in the lateral bin of WT and NrCAM null mice
(ANOVA; P,0.01), but not in the TZ and medial bins (P.0.05).
These results suggested that loss of NrCAM resulted in a reduced
ability of interstitial branches of VT axons to be attracted medially
to the future TZ, a process shown to require ephrinB1/EphB
signaling, L1-ankyrin interaction, and ALCAM [18,19,21,41].
To evaluate whether loss of NrCAM resulted in altered patterns
of RGC axon entrance into the SC, we measured the distribution
of DiI labeled VT axons entering into the SC at P3. For each
mouse, the entrance zone of the SC was divided into ten equal
bins: four bins located medial and six bins located lateral to the
correct TZ (Fig. 5C). The percentage of axons entering the SC in
each bin of WT (n= 4 mice; 146 axons) and NrCAM knockout
mice (n = 4 mice, 167 axons) was calculated and analyzed by
ANOVA. The entry position of VT axons in WT and NrCAM
null mice was enriched in the vicinity of the correct TZ and
decreased medially as well as laterally. There was no significant
difference in the location of WT and NrCAM null mutant axons
entering the SC (Fig. 5D). Thus, it is unlikely that laterally shifted
TZs in the NrCAM null mice were caused by impaired axonal
entrance into the SC.
EphB2 Phosphorylates NrCAM at the FIGQY Motif and
Inhibits Ankyrin Binding
Laterally displacement of TZs of temporal RGC axons in the
NrCAM null SC resembled the mediolateral retinotopic pheno-
type of EphB mutant mice [21,22]. EphB2 is the most prominent
EphB receptor exhibiting dorsal-low to ventral-high gradient in
the mouse retina [21,22]. The tyrosine residue within the L1
FIGQY motif is phosphorylated by EphB receptor kinases,
decreasing L1-ankyrin association [41]. However, there are
substantial differences in the cytoplasmic domains of NrCAM
and L1, including the presence of a carboxyl terminal PDZ
binding domain in NrCAM [42,43]. Therefore, we investigated
whether EphB receptor tyrosine kinases were able to phosphor-
ylate NrCAM at the cytoplasmic sequence. NrCAM and EphB2
expression plasmids were co-transfected into HEK293 cells for
transient expression, and NrCAM was analyzed for tyrosine
phosphorylation within the FIGQY sequence by immunoprecita-
tion of NrCAM followed by immunoblotting with a phospho-
specific p-FIGQY antibody, which was previously characterized
[41]. Results demonstrated that EphB2 effectively induced
tyrosine phosphorylation of NrCAM at the FIGQY motif, while
there was no endogenous phosphorylation of NrCAM in cells that
were transfected with NrCAM plasmid alone (Fig. 6A–B). In
addition, an EphB2 kinase dead mutant (EphB2K662R; EphB2
KD) [24] did not mediate phosphorylation of NrCAM at the
FIGQY motif (Fig. 6A), indicating that the kinase activity of
EphB2 was essential for FIGQY phosphorylation. Similar
transient expression of EphB1 (hemagglutinin (HA)-tagged) or
EphB3 (HA-tagged) showed that EphB1 was also effective at
inducing tyrosine phosphorylation of NrCAM at FIGQY, whereas
EphB3 was much less effective (Fig. 6B). Interestingly, each EphB
receptor (B1, B2, B3) co-immunoprecipitated with NrCAM from
transfected cells (Fig. 6B), demonstrating a molecular association
between NrCAM and EphB receptors.
To evaluate the consequence of altered EphB expression on
NrCAM phosphorylation at FIGQY in vivo, SC lysates were
prepared from WT, EphB1/3 double null, EphB1/2/3 triple null
and homozygous mice (P2–P3) expressing constitutively active
EphB2 (F620D). NrCAM was immunoprecipitated from the
lysates, immunoblotted with phospho-FIGQY antibodies, then
reprobed with NrCAM antibodies. Phosphorylation of NrCAM at
FIGQY was reduced in the SC of EphB1/3 and EphB1/2/3 null
mice compared to WT, while phospho-FIGQY on NrCAM was
increased in the EphB2 (F620D) mice with overactive kinase
activity (Fig. 6C). These results showed that NrCAM can be
phosphorylated on FIGQY in the SC during topographic mapping
dependent on EphB receptors. The residual phosphorylation in
EphB1/3 and EphB1/2/3 triple mutants may be due to other Eph
receptor kinases, or there may be compensatory phosphorylation
by EphB receptors when one is deleted.
To evaluate the ability of EphB2 to regulate NrCAM-ankyrin
binding, we used a cytofluorescence assay that measures recruit-
ment of EGFP-labeled ankyrinG (ankyrinG-EGFP) from the
cytoplasm to NrCAM in the cell membrane of transfected
HEK293 cells [29]. Like L1, NrCAM is a transmembrane cell
adhesion protein which localizes to the HEK293 cell membrane,
as indicated by red fluorescence (Fig. 6D, second row). Expression
of ankyrinG-EGFP alone resulted in a diffuse distribution of EGFP
EphB1/3 and EphB1/2/3 null mice compared to WT, while phospho-FIGQY on NrCAM was increased in the EphB2 F620D mice. D. Cytofluorescence
assay for recruitment of ankyrinG-EGFP to NrCAM in the plasma membrane of transfected HEK293 cells was visualized by confocal imaging. Boxes
above images indicate the expression plasmids used for transfection, while boxes at the left indicate fluorescence labeling of ankyrinG-EGFP or
NrCAM in the same cells. Corresponding differential contrast (DIC) images are shown below. AnkyrinG-EGFP localized within the cytoplasm of cells
expressing ankyrin alone, while co-expression of NrCAM led to the recruitment of ankyrinG-EGFP to the cell membrane, where NrCAM was localized.
When NrCAM was co-expressed with EphB2, ankyrinG-EGFP remained largely present in the cytoplasm. When NrCAM was co-expressed with EphB2
KD, ankyrinG-EGFP was recruited to the plasma membrane where NrCAM was localized in most cells, although occasionally some cytoplasmic
localization was seen. Scale bar = 15 mm. E. Quantification of the percentage of cells with ankyrinG-EGFP recruited to the plasma membrane of
HEK293 cells transfected as in C. NrCAM expression significantly increased ankyrinG-EGFP recruitment to the plasma membrane in ankyrin/NrCAM-
expressing cells as compared with ankyrin expression alone (Ankyrin/NrCAM: 8463%; Ankyrin: 361.6%). In cases of ankyrin/NrCAM/EphB2 co-
expression, ankyrinG-EGFP recruitment was strongly decreased (762%) compared to ankyrin/NrCAM expression. There was no significance decrease
in ankyrinG-EGFP recruitment in cases of ankyrin/NrCAM/EphB2 KD co-expression (8464%). Error bars show S.E.M. Asterisks indicate significant
differences in means (one-way ANOVA, Tukey’s post-hoc test, *p,0.001).
doi:10.1371/journal.pone.0073000.g006
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fluorescence in the cytoplasm, whereas co-transfection of NrCAM
with EGFP-ankyrinG led to recruitment of EGFP fluorescence to
the cell membrane where NrCAM was localized (Fig. 6D). When
EphB2 was co-transfected with NrCAM and ankyrinG-EGFP
under conditions shown to induce tyrosine phosphorylation of the
NrCAM FIGQY motif, ankyrinG-EGFP remained cytoplasmic
(Fig. 6D). In contrast, co-expression of the EphB2 KD mutant with
NrCAM and ankyrinG-EGFP, which does not induce NrCAM
phosphorylation at FIGQY, resulted in the recruitment of
ankyrinG to the cell membrane (Fig. 6D). Quantification of
percentage of cells with ankyrin recruited to the cell membrane
showed that greater than 80% of cells with NrCAM/ankyrinG co-
expression displayed membrane recruitment of ankyrinG, and that
this was significantly greater than in cells with ankyrinG expression
alone (3%) (Fig. 6E). In EphB2/NrCAM/ankyrinG transfections,
the percent of cells exhibiting ankyrinG recruitment to the cell
membrane was significantly decreased, compared with NrCAM/
ankyrinG transfections, and not different from ankyrinG transfec-
tion alone (Fig. 6E). In cells expressing EphB2 KD with NrCAM/
ankyrinG, the percent of cells with ankyrinG recruitment to cell
membrane was equivalent to cells with NrCAM/ankyrinG
expression (Fig. 6E). These results demonstrate that phosphory-
lation of NrCAM at the FIGQY motif by EphB2 kinase is
associated with inhibition of ankyrin recruitment to the plasma
membrane, where NrCAM is localized.
In summary, EphB2 induced tyrosine phosphorylation of
NrCAM at the ankyrin binding domain (FIGQY) and inhibited
ankyrin binding, consistent with an ability of EphB2 to modulate
the association of NrCAM with the actin cytoskeleton. Such
modulation may contribute to RGC interstitial branch orientation
in the SC in response to a high medial to low lateral ephrinB2
gradient, which facilitates topographic targeting of a subpopula-
tion of RGC axons along the mediolateral axis of the SC.
Discussion
Here we show that NrCAM contributes to retinocollicular
topography by regulating mediolateral targeting of temporal RGC
axons in the contralateral SC. Loss of NrCAM resulted in
pronounced lateral displacement of TZs of these axons within the
SC, and impaired interstitial branch orientation during refinement
of projections in development. EphB receptors, which regulate
mediolateral retinocollicular axon targeting, associated with and
phosphorylated NrCAM on tyrosine within the ankyrin binding
motif (FIGQY), decreasing ankyrin binding in an in vitro cell
model. These results suggest a molecular mechanism in which
reversible linkage of NrCAM to the actin cytoskeleton through
EphB phosphorylation promotes attraction of RGC axon branch-
es toward a medial-high ephrinB gradient in the SC, ensuring
appropriate mediolateral synaptic targeting of RGC axon
subpopulations.
The mediolateral targeting defects in NrCAM null mice closely
resembled those of mouse mutants in EphB1–3 and ephrinB1–2,
as well as L1 and ALCAM. Each of these mutants display laterally
displaced TZs of temporal and ventrotemporal RGC axons
[18,19,21,22]. EphB2/EphB3 mutant mice [21], L1 [17,18], and
ALCAM [19] null mice also exhibit impaired medial orientation of
interstitial axon branches, similar to NrCAM mutants. EphB
receptors associated with and differentially phosphorylated
NrCAM (EphB1, EphB2. EphB3) on the regulatory tyrosine
residue of the FIGQY ankyrin binding motif, decreasing ankyrin
recruitment in a kinase-dependent manner, as shown in transfect-
ed HEK293 cells. In vivo, the high penetrance of mapping errors
made by temporal axons in the NrCAM null SC approximated
that reported for EphB1/EphB2 and EphB2/EphB3 double
mutants, but was greater than EphB2 or EphB3 single mutants
[21,22], or EphB2 (F620D) homozygotes [22]. Accordingly, levels
of NrCAM phospho-FIGQY were decreased in the early postnatal
SC of EphB1/B3 double mutants and EphB1/B2/B3 triple
mutants, and increased in EphB2 (F620D) homozygotes. These
findings suggest that NrCAM is likely an effector of ephrinB
signaling from multiple EphB receptors important for topographic
targeting of RGC axons.
L1 is also phosphorylated by EphB receptors at its FIGQY
ankyrin binding domain, disrupting ankyrin recruitment [41].
However, EphB receptors differentially phosphorylated NrCAM
and L1. EphB1 and EphB2, which have large effects on temporal
axon mapping [22], phosphorylated both NrCAM and L1 [41],
whereas EphB3, which has a smaller effect on mapping [22],
phosphorylated L1 [41] and to a much lesser extent NrCAM. It is
therefore possible that different combinations of EphB receptors
expressed on temporal RGC axon subpopulations modulate
NrCAM- and L1-dependent adhesion to different degrees to
achieve refined regulation of retinocollicular targeting. The role of
NrCAM in retinal axon growth and branch orientation is in
accord with its ability to induce growth cone protrusions in
developing chick RGCs [44]. The expression of NrCAM on
retinal axons as well as on cells in the retino-recipient layers of the
SC suggests that homophilic interactions may also contribute to
targeting.
EphrinB2 and EphB1 promote repulsion of early-stage (E14)
VT retinal axons at the optic chiasm to form the ipsilateral
projection independent of NrCAM [45–47]. However, NrCAM is
required for a late-crossing subpopulation of VT axons to cross the
optic chiasm, as shown by aberrant ipsilateral projection in
NrCAM null mice [16]. The temporal axons mapped in our study
were not derived from this population, as they terminated in the
contralateral SC. NrCAM did not appear to influence retinal axon
outgrowth per se, because RGC axons grew to the SC, which they
reached at an appropriate age. Furthermore, NrCAM also did not
alter targeting or segregation of ipsilateral or contralateral
projections to the lateral geniculate nucleus of the dorsal thalamus
[15]. Normal targeting of ventral and dorsal RGC axons, as well
as axon entry into the SC, in NrCAM null mice indicated that pre-
target axon sorting of these axons, which chiefly controls
mediolateral mapping of ventral RGC axons [48], was most likely
unaffected. Similarly, EphB2/EphB3 null [48], ALCAM null [19],
L1 [17], and L1Y1229H mutant mice [18] show normal pre-target
axon sorting.
Countergradients of Neuropilin-2 on RGCs and Semaphorin3F
in the SC are suggestive of a potential role in anterior-posterior
retinocollicular mapping [49]. NrCAM associates with the
Semaphorin3F receptor Neuropilin-2 to mediate repulsive guid-
ance of thalamocortical [15] and anterior commissural axons [50].
A small shift in anterior-posterior location of eTZs in the NrCAM
null SC suggested that NrCAM/Neuropilin-2 interactions might
play a minor role in anterior-posterior mapping, or alternatively
reflect competitive interactions between normal and laterally
displaced axons [51]. Because loss of NrCAM did not alter the
lateral orientation of interstitial branches, it is unlikely to be
involved in the repellent counterforce mediated by Wnt3/Ryk
signaling [4].
The present research supports a mechanism in which NrCAM
regulates mediolateral retinocollicular mapping of temporal axon
subpopulations in response to ephrinB-EphB signaling to promote
directional branch extension vital to correct synaptic targeting and
development of an appropriate retinotopic map. Phosphorylation
of NrCAM at the FIGQY motif by EphBs in RGC axons may
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decrease ankyrin binding and cytoskeletal linkage, reducing their
affinity for substrate-bound ligands such as ALCAM, thereby
promoting branch attraction toward the medial high ephrinB
gradient in the SC.
The widespread expression of NrCAM and EphBs along axonal
projections in the brain suggests a potentially general role for the
mechanism described here in establishment of synaptic connec-
tivity and topography in specific regions of the developing nervous
system.
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